PCSK9 Inhibitors May Improve Cardiovascular Outcomes- Can We Afford Them?
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.08.383
https://www.valueinhealthjournal.com/article/S1098-3015(16)30963-9/fulltext
Section Title :
Disease-Specific Studies
Section Order :
2603
First Page :
A865
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)30963-9&doi=10.1016/j.jval.2016.08.383